Comorbid anxiety with depression predicts poor outcomes with a higher percentage of
treatment resistance than either disorder occurring alone. Overlap of anxiety and depression …

Background: Tardive dyskinesia (TD) is a movement disorder that causes involuntary,
repetitive body movements and is commonly seen in patients who are on long-term …

Purpose Tardive dyskinesia (TD) is a common but serious hyperkinetic movement disorder
and side effect of antipsychotic medications used to treat bipolar disorder (BD), major …

Tardive dyskinesia (TD) is a heterogeneous syndrome of involuntary hyperkinetic
movements that is often persistent and occurs belatedly during treatment with antipsychotics …

The main purpose of this study was to develop nanosuspensions of ziprasidone
hydrochloride monohydrate (ZHM), the BCS Class II antipsychotic agent, to solve its water …

Dopamine-receptor blocking agent-associated akathisia (DRBA-A) is an adverse effect that
can significantly limit the use of these important medications for the treatment of a variety of …

Tardive dyskinesia (TD) is a serious, disabling and potentially permanent, neurological
hyperkinetic movement disorder that occurs after months or years of taking dopamine …

Background An increasing number of prescribers are using antipsychotics for treatment of
anxiety disorders, despite lack of FDA-approved indications and mixed efficacy results from …

Correlates of the Abnormal Involuntary Movement Scale in Vet... : Journal of Clinical
Psychopharmacology Correlates of the Abnormal Involuntary Movement Scale in Veterans With …

Purpose/Background: To inform cost-benefit decisions for veterans, the risk of tardive
dyskinesia (TD) and its impact on comorbidities and outcomes were assessed …